Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonnet BioTherapeutics Holdings, Inc.

1.37
+0.01000.74%
Post-market: 1.380.0099+0.72%16:06 EDT
Volume:8.35K
Turnover:11.36K
Market Cap:4.20M
PE:-0.15
High:1.39
Open:1.38
Low:1.33
Close:1.36
Loading ...
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 29, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Correspondence

Form CORRESP - Correspondence
Jan 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 28, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 18, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 07, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Oct 24, 2023

Correspondence

Form CORRESP - Correspondence
Oct 24, 2023

Correspondence

Form CORRESP - Correspondence
Oct 20, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 05, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 29, 2023

Correspondence

Form CORRESP - Correspondence
Sep 29, 2023

Correspondence

Form CORRESP - Correspondence
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence